Collagen hydrolysate for use in prevention and/or treatment of post intensive care syndrome (pics)
AssigneeRousselot B.V.
InventorsBarbara De Klerk-Engels, Elien Monique Gevaert, Praneeth Reddy Kuninty, Janne Prawitt, Nicolina Virgilio
Life of this patent
Estimating the term…
Abstract
The present invention relates to a use of collagen hydrolysate after intensive care unit (ICU) stay. The collagen hydrolysate improves the recovery and prevents and/or treats post intensive care syndrome (PICS) after ICU stay. The collagen hydrolysate is preferably administered as a supplement in the context of ICU stay and/or PICS. Collagen hydrolysate is generally-accepted to be safe and therefore can be taken as a preventive and long-term measure.
Claims10
A method for improving the recovery of a subject after intensive care unit stay comprising administering a collagen hydrolysate to the subject, wherein the collagen hydrolysate is derived from one or more of porcine, bovine or fish and has an average molecular weight of no more than 5,000 Daltons (Da), and wherein improving the recovery of the subject after intensive care unit stay comprises prevention and/or treatment of post-intensive care syndrome (PICS).
Dependencies are inferred from the claim text.